<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>The Soul of Biotech</title>
	<atom:link href="http://www.thesoulofbiotech.com/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.thesoulofbiotech.com</link>
	<description>Laughter is the best medicine -- but let's cure cancer anyway.</description>
	<lastBuildDate>Fri, 27 Apr 2012 21:02:31 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3.2</generator>
		<item>
		<title>Four Themes to Watch in Personalized Medicine</title>
		<link>http://www.thesoulofbiotech.com/2012/01/30/four-themes-to-watch-in-personalized-medicine/</link>
		<comments>http://www.thesoulofbiotech.com/2012/01/30/four-themes-to-watch-in-personalized-medicine/#comments</comments>
		<pubDate>Mon, 30 Jan 2012 23:45:27 +0000</pubDate>
		<dc:creator>admin</dc:creator>
				<category><![CDATA[conference]]></category>
		<category><![CDATA[pharmacogenomics]]></category>
		<category><![CDATA[talks]]></category>

		<guid isPermaLink="false">http://www.thesoulofbiotech.com/?p=256</guid>
		<description><![CDATA[This post originally appeared as a guest post on the Xconomy news site. Good morning from Mountain View, CA, and from the close of the 2012 Personalized Medicine World Conference, which brought together thought leaders of business, government, healthcare-delivery, research and technology. Four themes that emerged from this year’s program: Greater optimism, triggered by the [...]
No related posts.]]></description>
		<wfw:commentRss>http://www.thesoulofbiotech.com/2012/01/30/four-themes-to-watch-in-personalized-medicine/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>I&#8217;m a guest on The MBA Show!</title>
		<link>http://www.thesoulofbiotech.com/2011/03/04/im-a-guest-on-the-mba-show/</link>
		<comments>http://www.thesoulofbiotech.com/2011/03/04/im-a-guest-on-the-mba-show/#comments</comments>
		<pubDate>Fri, 04 Mar 2011 15:19:25 +0000</pubDate>
		<dc:creator>Jonathan</dc:creator>
				<category><![CDATA[talks]]></category>

		<guid isPermaLink="false">http://www.thesoulofbiotech.com/?p=241</guid>
		<description><![CDATA[Yesterday, I taped a healthcare-focused episode of The MBA Show, hosted by Miro Kazakoff and Tom Rose. I had a great time prepping the show with Miro and Tom this week. They&#8217;re smart, creative and easy to talk to. If you haven&#8217;t started watching yet, don&#8217;t miss out. Their viewership has been picking up a [...]
No related posts.]]></description>
		<wfw:commentRss>http://www.thesoulofbiotech.com/2011/03/04/im-a-guest-on-the-mba-show/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>What Are Follow-on Biologics? Will They Really Save Us Billions Of Dollars?</title>
		<link>http://www.thesoulofbiotech.com/2009/06/29/what-are-follow-on-biologics-will-they-really-save-us-billions-of-dollars/</link>
		<comments>http://www.thesoulofbiotech.com/2009/06/29/what-are-follow-on-biologics-will-they-really-save-us-billions-of-dollars/#comments</comments>
		<pubDate>Mon, 29 Jun 2009 20:27:18 +0000</pubDate>
		<dc:creator>Jonathan</dc:creator>
				<category><![CDATA[follow-on biologics]]></category>
		<category><![CDATA[regulations]]></category>

		<guid isPermaLink="false">http://www.thesoulofbiotech.com/?p=175</guid>
		<description><![CDATA[This post originally appeared here as a guest post on the Better Health blog network. It has since also appeared here on the I Am Biotech blog. Much has been made of the recent pressure on the FDA to create a pathway for follow-on biologics. On June 9, 2009, Rep. Henry Waxman, chair of the [...]
No related posts.]]></description>
		<wfw:commentRss>http://www.thesoulofbiotech.com/2009/06/29/what-are-follow-on-biologics-will-they-really-save-us-billions-of-dollars/feed/</wfw:commentRss>
		<slash:comments>2</slash:comments>
		</item>
		<item>
		<title>6/24: FDA Transparency Meeting</title>
		<link>http://www.thesoulofbiotech.com/2009/06/22/624-fda-transparency-meeting/</link>
		<comments>http://www.thesoulofbiotech.com/2009/06/22/624-fda-transparency-meeting/#comments</comments>
		<pubDate>Mon, 22 Jun 2009 20:08:43 +0000</pubDate>
		<dc:creator>Jonathan</dc:creator>
				<category><![CDATA[regulations]]></category>

		<guid isPermaLink="false">http://www.thesoulofbiotech.com/2009/06/22/624-fda-transparency-meeting/</guid>
		<description><![CDATA[I&#8217;ll be attending the FDA Transparency Meeting on Wednesday. To catch my livetweets, follow me on Twitter. Posted via email from sheffi&#8217;s posterous No related posts.
No related posts.]]></description>
		<wfw:commentRss>http://www.thesoulofbiotech.com/2009/06/22/624-fda-transparency-meeting/feed/</wfw:commentRss>
		<slash:comments>1</slash:comments>
		</item>
		<item>
		<title>Posterous</title>
		<link>http://www.thesoulofbiotech.com/2009/06/22/posterous/</link>
		<comments>http://www.thesoulofbiotech.com/2009/06/22/posterous/#comments</comments>
		<pubDate>Mon, 22 Jun 2009 18:51:24 +0000</pubDate>
		<dc:creator>Jonathan</dc:creator>
				<category><![CDATA[Uncategorized]]></category>

		<guid isPermaLink="false">http://www.thesoulofbiotech.com/2009/06/22/posterous/</guid>
		<description><![CDATA[Giving Posterous a whirl&#8230; Posted via email from sheffi&#8217;s posterous No related posts.
No related posts.]]></description>
		<wfw:commentRss>http://www.thesoulofbiotech.com/2009/06/22/posterous/feed/</wfw:commentRss>
		<slash:comments>1</slash:comments>
		</item>
		<item>
		<title>My BIL &#8217;09 talk video is online!</title>
		<link>http://www.thesoulofbiotech.com/2009/03/10/my-bil-09-talk-video-is-online/</link>
		<comments>http://www.thesoulofbiotech.com/2009/03/10/my-bil-09-talk-video-is-online/#comments</comments>
		<pubDate>Wed, 11 Mar 2009 06:39:17 +0000</pubDate>
		<dc:creator>Jonathan</dc:creator>
				<category><![CDATA[bil]]></category>
		<category><![CDATA[conference]]></category>
		<category><![CDATA[pharmacogenomics]]></category>
		<category><![CDATA[regulations]]></category>
		<category><![CDATA[talks]]></category>

		<guid isPermaLink="false">http://www.thesoulofbiotech.com/?p=131</guid>
		<description><![CDATA[The Promise and the Peril of Personalized Medicine from Jeriaska on Vimeo. Many thanks to Drew Reynolds for taping this and editing together this abbreviated version. The uncut talk was about ten minutes long &#8212; I started out explaining what treatment-response biomarkers are, and how they can improve patient outcomes and save money for payors. [...]
No related posts.]]></description>
		<wfw:commentRss>http://www.thesoulofbiotech.com/2009/03/10/my-bil-09-talk-video-is-online/feed/</wfw:commentRss>
		<slash:comments>2</slash:comments>
		</item>
		<item>
		<title>EEOC invites comment on GINA</title>
		<link>http://www.thesoulofbiotech.com/2009/02/28/eeoc-invites-comment-on-gina/</link>
		<comments>http://www.thesoulofbiotech.com/2009/02/28/eeoc-invites-comment-on-gina/#comments</comments>
		<pubDate>Sat, 28 Feb 2009 18:22:31 +0000</pubDate>
		<dc:creator>Jonathan</dc:creator>
				<category><![CDATA[genetics]]></category>
		<category><![CDATA[pharmacogenomics]]></category>
		<category><![CDATA[regulations]]></category>

		<guid isPermaLink="false">http://www.thesoulofbiotech.com/?p=125</guid>
		<description><![CDATA[
No related posts.]]></description>
		<wfw:commentRss>http://www.thesoulofbiotech.com/2009/02/28/eeoc-invites-comment-on-gina/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Notes from the 2009 Harvard Business School Healthcare Conference (Part 3)</title>
		<link>http://www.thesoulofbiotech.com/2009/01/27/notes-from-the-2009-harvard-business-school-healthcare-conference-part-3/</link>
		<comments>http://www.thesoulofbiotech.com/2009/01/27/notes-from-the-2009-harvard-business-school-healthcare-conference-part-3/#comments</comments>
		<pubDate>Wed, 28 Jan 2009 01:15:23 +0000</pubDate>
		<dc:creator>Jonathan</dc:creator>
				<category><![CDATA[conference]]></category>
		<category><![CDATA[hbs]]></category>

		<guid isPermaLink="false">http://www.thesoulofbiotech.com/?p=118</guid>
		<description><![CDATA[In the afternoon, I attended the Biotech/Pharma panel, which was fascinating. A lot of great questions were tackled. I&#8217;ve laid out the three best ones, and the panel&#8217;s responses. Is the FIPCO (fully integrated pharmaceutical company) model still viable, and if not, then how will it evolve? On one side was William Annett of Genentech, [...]
No related posts.]]></description>
		<wfw:commentRss>http://www.thesoulofbiotech.com/2009/01/27/notes-from-the-2009-harvard-business-school-healthcare-conference-part-3/feed/</wfw:commentRss>
		<slash:comments>2</slash:comments>
		</item>
		<item>
		<title>Notes from the 2009 Harvard Business School Healthcare Conference (Part 2)</title>
		<link>http://www.thesoulofbiotech.com/2009/01/22/notes-from-the-2009-harvard-business-school-healthcare-conference-part-2/</link>
		<comments>http://www.thesoulofbiotech.com/2009/01/22/notes-from-the-2009-harvard-business-school-healthcare-conference-part-2/#comments</comments>
		<pubDate>Thu, 22 Jan 2009 20:33:51 +0000</pubDate>
		<dc:creator>Jonathan</dc:creator>
				<category><![CDATA[conference]]></category>
		<category><![CDATA[enbrel]]></category>
		<category><![CDATA[hbs]]></category>
		<category><![CDATA[pharmacogenomics]]></category>

		<guid isPermaLink="false">http://www.thesoulofbiotech.com/?p=109</guid>
		<description><![CDATA[The next session I attended was the personalized medicine panel, which was new this year. The panelists spoke to a standing-room-only crowd in an HBS lecture hall. The panelists briefly explained what personalized medicine was, and emphasized its importance as technology began to deliver whole genome sequences for less and less money. The first human [...]
Related posts:<ol>
<li><a href='http://www.thesoulofbiotech.com/2012/01/30/four-themes-to-watch-in-personalized-medicine/' rel='bookmark' title='Four Themes to Watch in Personalized Medicine'>Four Themes to Watch in Personalized Medicine</a></li>
</ol>]]></description>
		<wfw:commentRss>http://www.thesoulofbiotech.com/2009/01/22/notes-from-the-2009-harvard-business-school-healthcare-conference-part-2/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Notes from the 2009 Harvard Business School Healthcare Conference (Part 1)</title>
		<link>http://www.thesoulofbiotech.com/2009/01/22/notes-from-the-2009-harvard-business-school-healthcare-conference-part-1/</link>
		<comments>http://www.thesoulofbiotech.com/2009/01/22/notes-from-the-2009-harvard-business-school-healthcare-conference-part-1/#comments</comments>
		<pubDate>Thu, 22 Jan 2009 07:48:08 +0000</pubDate>
		<dc:creator>Jonathan</dc:creator>
				<category><![CDATA[conference]]></category>
		<category><![CDATA[hbs]]></category>

		<guid isPermaLink="false">http://www.thesoulofbiotech.com/?p=97</guid>
		<description><![CDATA[On Saturday, January 17th, I took a break from helping organize this year&#8217;s Mystery Hunt to attend the 6th Annual HBS Healthcare Conference in Boston, MA. I took extensive notes on the conference, and will spread out my notes across a few posts. The leading keynote featured Lonnie Smith of Intuitive Surgical, which makes robotic [...]
No related posts.]]></description>
		<wfw:commentRss>http://www.thesoulofbiotech.com/2009/01/22/notes-from-the-2009-harvard-business-school-healthcare-conference-part-1/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>

<!-- Dynamic Page Served (once) in 1337463847.331 seconds -->

